trending Market Intelligence /marketintelligence/en/news-insights/trending/tid7e6cj1bcrb5hmxsx67w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Alere seeking to reinstate Medicare privileges of diabetes unit

Mining Exploration Insights – May 2020

Essential Energy Insights - May 14, 2020

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Credit Analytics Case Study: Provogue (India) Limited and Shree Renuka Sugars


Alere seeking to reinstate Medicare privileges of diabetes unit

Alere Inc. is asking the Centers for Medicare & Medicaid Services to reconsider its decision to revoke the Medicare billing privileges of its diabetes diagnostic business, Arriva Medical.

The company filed an appeal with the CMS administrative law judge to reinstate Arriva's billing status for diabetes testing more than a month after it was revoked.

Meanwhile, the company filed a complaint with the U.S. District Court for the District of Columbia to prevent the CMS from terminating Arriva's billing status pending the outcome of the appeal.

The CMS revoked Arriva's Medicare supplier billing number Nov. 4 and barred the company from re-enrolling in the program for a period of three years after a string it filed claims for 211 dead patients.